Results 71 to 80 of about 2,505,841 (292)

Differential expression of cancer‐related genes supports prediction of poor response to first‐line treatments in T‐ALL pediatric patients with high minimal residual disease

open access: yesMolecular Oncology, EarlyView.
In the present work, we have identified a transcriptional signature based on the differential expression of six genes (BCL2&MAST4, HSH2D&LAT2, METRN&PITPNM2) that would facilitate the early detection of T‐cell acute lymphoblastic leukemia (T‐ALL) patients prone to a poor treatment response and could be implemented at diagnosis, along with other risk ...
Antonio Lahera   +11 more
wiley   +1 more source

Winning by Intelligence: Leveraging the Innovative Advantages of Intelligent Transformation in Market Competition

open access: yesSystems
Intelligent transformation plays an important role in enhancing innovation capabilities. This study utilizes data from 5000 A-share firms in China to investigate the effects of intelligent transformation on innovation capability and to elucidate the ...
Jingwen Lv, Lu Feng, Wei Xiao, Wei He
doaj   +1 more source

Innovating in Journalism with Newsgames: An Exploratory Study in Portugal

open access: yes
Journalism strives to keep up with the new paradigm shift that characterizes Industry 4.0. It finds in innovation possibilities to respond to the various and constant digital changes that impact journalistic practices and to find new business models. Journalistic innovation is mostly associated with the development of apps and new formats for content ...
Frutuoso Costa, Bruno   +1 more
openaire   +2 more sources

Hijacking emergency granulopoiesis: Neutrophil ontogeny and reprogramming in cancer

open access: yesMolecular Oncology, EarlyView.
Neutrophils are highly plastic innate immune cells; their functions in cancer extend beyond the tumour microenvironment. This Review summarises current understanding of neutrophil maturation and heterogeneity and highlights tumour‐induced granulopoiesis as a systemic programme that expands immature, immunosuppressive neutrophils via tumour‐derived ...
Gabriela Marinescu, Yi Feng
wiley   +1 more source

Investigating co-innovation in exploratory partnerships: An analytical framework based on design theory [PDF]

open access: yes
Intensive innovation contexts push organizations to search for new partnerships in order to explore value creation opportunities and to access external resources.
Akın Kazakçı   +2 more
core  

Exit Statement : 2001-2009 CRC for Construction Innovation [PDF]

open access: yes, 2009
The Cooperative Research Centre (CRC) for Construction Innovation is Australia’s national centre for research and innovation focused on the needs of the property, design, construction and facility management sectors. The period covered by this report is

core  

Loss of IGF‐1R impairs DNA‐PKcs recruitment to chromatin leading to defective end‐joining

open access: yesMolecular Oncology, EarlyView.
IGF‐1R promotes radioresistance by facilitating DNA‐PKcs recruitment to chromatin, enabling non‐homologous end‐joining (NHEJ) repair of double‐strand breaks. Inhibition or loss of IGF‐1R disrupts this recruitment to damage sites, driving compensatory reliance on microhomology‐mediated end‐joining (MMEJ) repair.
Matthew O. Ellis   +3 more
wiley   +1 more source

Knowledge management driven leadership, culture and innovation success – an integrative model [PDF]

open access: yes, 2015
Purpose - This article examines the relation between knowledge management (KM) driven leadership, culture and innovation success of knowledge-intensive small and medium sized companies.
Zięba, M   +3 more
core  

Harnessing capabilities and practices for sourcing innovation: an exploratory study

open access: yes, 2017
Sourcing innovation has become prevalent only in the recent years; therefore, researchers address the practice of sourcing innovation using various terminologies and there is no fixed definition in the extant literature for sourcing innovation.
Christopher Rajkumar
core   +1 more source

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

open access: yesMolecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy